The use of aggregation-induced emission probe doped silica nanoparticles for the immunoassay of human epididymis protein 4
- 30 August 2019
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 144 (20) , 6136-6142
Abstract
A sensitive sandwich immunoassay for the sensing of human epididymis protein 4 (HE4) is developed based on aggregation-induced emission probe doped silica nanoparticles. Fluorescent silica nanoparticles (TSiO2) with excellent performance were prepared using a tetraphenylethylene based probe (TPE-C4-4) to produce a controlled aggregation effect, and HE4 was detected using antibody-functionalized fluorescent silica nanoparticles. The fluorescent silica nanoparticles possess good photophysical properties. The TSiO2 NPs were surface modified with carboxyl groups, and the antibody was covalently attached onto the surface of the nanoparticles. In addition, magnetic beads were modified with N-hydroxysulfosuccinimide sodium salt (NHS) on their surface, capable of forming stable peptide bonds with the antibody. TSiO2 NPs modified by an antibody and the magnetic beads modified by an antibody were used for the sandwich immunoassay for HE4 protein. The assay is quite sensitive and selective. The detection limit of HE4 is estimated to be 40 pM. The assay shows promising applications for the early diagnosis of ovarian cancer and the development of ovarian cancer-related drugs.Keywords
Funding Information
- National Natural Science Foundation of China (21874128)
- National Natural Science Foundation of China (21561162004)
- National Natural Science Foundation of China (51761145102)
- Natural Science Foundation of Jilin Province (20190201069JC)
- Natural Science Foundation of Jilin Province (20160414040GH)
- Natural Science Foundation of Jilin Province (20160520127JH)
This publication has 21 references indexed in Scilit:
- Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancerGynecologic Oncology, 2013
- The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumorsJournal of Ovarian Research, 2013
- Detection of serum human epididymis secretory protein 4 in patients with ovarian cancer using a label-free biosensor based on localized surface plasmon resonanceInternational Journal of Nanomedicine, 2012
- Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant DiseasesClinical Chemistry, 2011
- Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-careLab on a Chip, 2011
- Human Epididymis Protein 4 (HE4) as a Serum Tumor Biomarker in Patients With Ovarian CarcinomaInternational Journal of Gynecological Cancer, 2011
- Enzyme‐Responsive Multifunctional Magnetic Nanoparticles for Tumor Intracellular Drug Delivery and ImagingChemistry – An Asian Journal, 2011
- Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patientsBritish Journal of Cancer, 2011
- Detection of the HE4 protein in urine as a biomarker for ovarian neoplasmsCancer Letters, 2010
- Magnetic bead based assay for C-reactive protein using quantum-dot fluorescence labeling and immunoaffinity separationThe Analyst, 2009